[HTML][HTML] GLI1: a therapeutic target for cancer

JT Avery, R Zhang, RJ Boohaker - Frontiers in oncology, 2021 - frontiersin.org
GLI1 is a transcriptional effector at the terminal end of the Hedgehog signaling (Hh) pathway
and is tightly regulated during embryonic development and tissue patterning/differentiation …

Smart drug-delivery systems for cancer nanotherapy

P Sanchez-Moreno, JL Ortega-Vinuesa… - Current drug …, 2018 - ingentaconnect.com
Background: Despite all the advances achieved in the field of tumor-biology research, in
most cases conventional therapies including chemotherapy are still the leading choices. The …

Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy

C Wu, X Zhu, W Liu, T Ruan, K Tao - OncoTargets and therapy, 2017 - Taylor & Francis
Colorectal cancer (CRC) is one of the most common gastrointestinal cancers worldwide. It is
a complicated and often fatal cancer, and is related to a high disease-related mortality …

A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent

M Antoszczak - European Journal of Medicinal Chemistry, 2019 - Elsevier
Tumors are phenotypically heterogeneous and include a small sub-population of cancer
cells (2–5% of the tumor mass) with stem-cell like properties. The cancer stem cell …

Implications of stemness-related signaling pathways in breast cancer response to therapy

V Angeloni, P Tiberio, V Appierto… - Seminars in cancer biology, 2015 - Elsevier
There is accumulating evidence that breast cancer may arise from a small subpopulation of
transformed mammary stem/progenitor cells, termed breast cancer-initiating cells (BCICs) …

Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism

MB Garcia-Ortega, GJ Lopez, G Jimenez… - Expert Reviews in …, 2017 - cambridge.org
The protein kinase R (PKR, also called EIF2AK2) is an interferon-inducible double-stranded
RNA protein kinase with multiple effects on cells that plays an active part in the cellular …

[HTML][HTML] Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells

SY Ju, CYF Huang, WC Huang, Y Su - Cell death & disease, 2015 - nature.com
Accumulating evidence shows that colorectal cancer stem cells (CRSCs) are largely
responsible for the metastasis and relapse of colorectal cancer (CRC) after therapy. Hence …

[HTML][HTML] Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution

A Aguilera-Garrido, P Graván… - Biomedicine & …, 2023 - Elsevier
Maslinic acid (MA) is a natural pentacyclic triterpenoid with inherent antitumor activity which
has a very low solubility in water. MA solid lipid nanoparticles (SLNs) were prepared using …

[HTML][HTML] Anti-cancerous potential of polysaccharides derived from wheat cell culture

A Murtazina, G Ruiz Alcala, Y Jimenez-Martinez… - Pharmaceutics, 2022 - mdpi.com
There is a global need to discover effective anti-cancerous compounds from natural sources.
Cultivated wheat cells can be a valuable source of non-toxic or low toxic plant-derived …

New perspectives on β-catenin control of cell fate and proliferation in colon cancer

Y Yang, JJ Yang, H Tao, WS Jin - Food and chemical toxicology, 2014 - Elsevier
Colorectal cancer is a major health problem worldwide. Aberrant activation of the Wingless-
type mouse mammary tumor virus integration site family (Wnt)/β-catenin signaling pathway …